BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37792220)

  • 1. Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
    Dadey DYA; Medress ZA; Sharma M; Ugiliweneza B; Wang D; Rodrigues A; Parker J; Burton E; Williams B; Han SS; Boakye M; Skirboll S
    J Neurooncol; 2023 Sep; 164(3):655-662. PubMed ID: 37792220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
    Mahjoub H; Loya A; Ayaz T; Weng CY
    Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
    Farr DE; Thomas A; Khan SA; Schroeder MC
    Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
    Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
    PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database study.
    Joshi U; Bhattarai A; Gaire S; Gill S; Agrawal V; Yadav SK; Low SK; Dhakal P; Bhatt VR; Kouides PA
    Leuk Lymphoma; 2022 Dec; 63(14):3456-3461. PubMed ID: 36120968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX; Nelson RA; Kim JY; Raz DJ
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
    Yang Z; Liu L; Leng K; Shi G
    J Gastroenterol Hepatol; 2023 Sep; 38(9):1474-1484. PubMed ID: 37114675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second primary malignancies after ocular adnexal lymphoma diagnosis.
    Loya A; Ramachandran V; Ayaz T; Weng CY
    BMC Ophthalmol; 2021 Apr; 21(1):162. PubMed ID: 33827494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
    Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
    J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma: A SEER-Based Analysis.
    Eid E; Maloney NJ; Cai ZR; Zaba LC; Kibbi N; John EM; Linos E
    JAMA Dermatol; 2023 Nov; 159(11):1248-1252. PubMed ID: 37703005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma.
    Zhang GT; Liu Q; Zuo FX; Liu HJ; Wang SQ; Yuan Q; Liu AS; Hu K; Meng XL; Wang WJ; Qian HP; Wan JH; Cai HQ
    BMC Cancer; 2023 Jan; 23(1):104. PubMed ID: 36717819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Risk of Subsequent Malignant Neoplasms Among Childhood and Adolescent Lymphoma Survivors (1975-2013): A Population-Based Predictive Nomogram.
    Liu J; Zheng Q; Beeraka NM; Zhang X; Li T; Song R; Zhao D; Fan R
    Oncologist; 2023 Sep; 28(9):e765-e773. PubMed ID: 37177980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study.
    Wei JL; Jiang YZ; Shao ZM
    Int J Clin Oncol; 2019 Aug; 24(8):934-940. PubMed ID: 30888527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Second Primary Tumors After Childhood and Adolescent Ovarian Malignancies: A SEER Analysis (1973-2011).
    Nasioudis D; Ramer I; Sisti G; Fambrini M
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):522-5. PubMed ID: 26152647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.